ELISA Kit for Insulin Like Protein 3 (INSL3)

RLNL; RLF; Relaxin-Like Factor,Leydig Cell; Leydig insulin-like peptide


This assay has high sensitivity and excellent specificity for detection of Insulin Like Protein 3 (INSL3).
No significant cross-reactivity or interference between Insulin Like Protein 3 (INSL3) and analogues was observed.


Matrices listed below were spiked with certain level of recombinant Insulin Like Protein 3 (INSL3) and the recovery rates were calculated by comparing the measured value to the expected amount of Insulin Like Protein 3 (INSL3) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-97 88
EDTA plasma(n=5) 88-103 98
heparin plasma(n=5) 80-98 87


Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin Like Protein 3 (INSL3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin Like Protein 3 (INSL3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%


The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Insulin Like Protein 3 (INSL3) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 92-105% 81-98% 99-105% 83-98%
EDTA plasma(n=5) 96-103% 79-96% 84-95% 93-101%
heparin plasma(n=5) 82-98% 88-95% 80-101% 84-99%


The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.



Magazine Citations
Adv Med Sci. Are anti-MĂźllerian hormone and its receptor polymorphism associated with the hormonal condition of undescended testes? Pubmed:27162065
Journal of Clinical Research in Pediatric Endocrinology Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. pubmed:27125339
Bioscience, Biotechnology, and Biochemistry Salivary lactoferrin is transferred into the brain via the sublingual route pubmed:28351211
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPD873Hu01 Recombinant Insulin Like Protein 3 (INSL3) Positive Control; Immunogen; SDS-PAGE; WB.
PAD873Hu01 Polyclonal Antibody to Insulin Like Protein 3 (INSL3) WB; IHC; ICC; IP.
MAD873Hu21 Monoclonal Antibody to Insulin Like Protein 3 (INSL3) WB; IHC; ICC; IP.
SED873Hu ELISA Kit for Insulin Like Protein 3 (INSL3) Enzyme-linked immunosorbent assay for Antigen Detection.